Bailard’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bailard’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22,000	Closed	-$829K	–	779
2021 Q1	$829K	Buy	+22,000	New	+$549K	0.03%	284
2019 Q4	–	Sell	-13,000	Closed	-$50K	–	627
2019 Q3	$50K	Hold	13,000	–	–	﹤0.01%	528
2019 Q2	$78K	Buy	13,000 +2,500	+24%	+$23.9K	﹤0.01%	533
2019 Q1	$141K	Buy	+10,500	New	+$120K	0.01%	518

Bailard's FPRX Position: Q2 2021 in Review

Bailard sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 22,000 shares — an estimated $829K sold.

Bailard first reported a position in FPRX in Q1 2019 and held it in 4 quarters. The position peaked at $829K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Bailard reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Bailard sold 22,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $829K.
Bailard first reported a position in Five Prime Therapeutics, Inc. in Q1 2019 and held it in 4 quarters.
Bailard's Five Prime Therapeutics, Inc. position peaked at $829K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Bailard's 13F filing for Q2 2021, filed 13 Aug 2021.